Cargando…
From OPC to Oligodendrocyte: An Epigenetic Journey
Oligodendrocytes provide metabolic and functional support to neuronal cells, rendering them key players in the functioning of the central nervous system. Oligodendrocytes need to be newly formed from a pool of oligodendrocyte precursor cells (OPCs). The differentiation of OPCs into mature and myelin...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830107/ https://www.ncbi.nlm.nih.gov/pubmed/31614602 http://dx.doi.org/10.3390/cells8101236 |
_version_ | 1783465711025258496 |
---|---|
author | Tiane, Assia Schepers, Melissa Rombaut, Ben Hupperts, Raymond Prickaerts, Jos Hellings, Niels van den Hove, Daniel Vanmierlo, Tim |
author_facet | Tiane, Assia Schepers, Melissa Rombaut, Ben Hupperts, Raymond Prickaerts, Jos Hellings, Niels van den Hove, Daniel Vanmierlo, Tim |
author_sort | Tiane, Assia |
collection | PubMed |
description | Oligodendrocytes provide metabolic and functional support to neuronal cells, rendering them key players in the functioning of the central nervous system. Oligodendrocytes need to be newly formed from a pool of oligodendrocyte precursor cells (OPCs). The differentiation of OPCs into mature and myelinating cells is a multistep process, tightly controlled by spatiotemporal activation and repression of specific growth and transcription factors. While oligodendrocyte turnover is rather slow under physiological conditions, a disruption in this balanced differentiation process, for example in case of a differentiation block, could have devastating consequences during ageing and in pathological conditions, such as multiple sclerosis. Over the recent years, increasing evidence has shown that epigenetic mechanisms, such as DNA methylation, histone modifications, and microRNAs, are major contributors to OPC differentiation. In this review, we discuss how these epigenetic mechanisms orchestrate and influence oligodendrocyte maturation. These insights are a crucial starting point for studies that aim to identify the contribution of epigenetics in demyelinating diseases and may thus provide new therapeutic targets to induce myelin repair in the long run. |
format | Online Article Text |
id | pubmed-6830107 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-68301072019-11-20 From OPC to Oligodendrocyte: An Epigenetic Journey Tiane, Assia Schepers, Melissa Rombaut, Ben Hupperts, Raymond Prickaerts, Jos Hellings, Niels van den Hove, Daniel Vanmierlo, Tim Cells Review Oligodendrocytes provide metabolic and functional support to neuronal cells, rendering them key players in the functioning of the central nervous system. Oligodendrocytes need to be newly formed from a pool of oligodendrocyte precursor cells (OPCs). The differentiation of OPCs into mature and myelinating cells is a multistep process, tightly controlled by spatiotemporal activation and repression of specific growth and transcription factors. While oligodendrocyte turnover is rather slow under physiological conditions, a disruption in this balanced differentiation process, for example in case of a differentiation block, could have devastating consequences during ageing and in pathological conditions, such as multiple sclerosis. Over the recent years, increasing evidence has shown that epigenetic mechanisms, such as DNA methylation, histone modifications, and microRNAs, are major contributors to OPC differentiation. In this review, we discuss how these epigenetic mechanisms orchestrate and influence oligodendrocyte maturation. These insights are a crucial starting point for studies that aim to identify the contribution of epigenetics in demyelinating diseases and may thus provide new therapeutic targets to induce myelin repair in the long run. MDPI 2019-10-11 /pmc/articles/PMC6830107/ /pubmed/31614602 http://dx.doi.org/10.3390/cells8101236 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Tiane, Assia Schepers, Melissa Rombaut, Ben Hupperts, Raymond Prickaerts, Jos Hellings, Niels van den Hove, Daniel Vanmierlo, Tim From OPC to Oligodendrocyte: An Epigenetic Journey |
title | From OPC to Oligodendrocyte: An Epigenetic Journey |
title_full | From OPC to Oligodendrocyte: An Epigenetic Journey |
title_fullStr | From OPC to Oligodendrocyte: An Epigenetic Journey |
title_full_unstemmed | From OPC to Oligodendrocyte: An Epigenetic Journey |
title_short | From OPC to Oligodendrocyte: An Epigenetic Journey |
title_sort | from opc to oligodendrocyte: an epigenetic journey |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830107/ https://www.ncbi.nlm.nih.gov/pubmed/31614602 http://dx.doi.org/10.3390/cells8101236 |
work_keys_str_mv | AT tianeassia fromopctooligodendrocyteanepigeneticjourney AT schepersmelissa fromopctooligodendrocyteanepigeneticjourney AT rombautben fromopctooligodendrocyteanepigeneticjourney AT huppertsraymond fromopctooligodendrocyteanepigeneticjourney AT prickaertsjos fromopctooligodendrocyteanepigeneticjourney AT hellingsniels fromopctooligodendrocyteanepigeneticjourney AT vandenhovedaniel fromopctooligodendrocyteanepigeneticjourney AT vanmierlotim fromopctooligodendrocyteanepigeneticjourney |